Skip to main content
Acute Lymphoblastic LeukemiaScientific PublicationsTyrosine Kinase Inhibitors

OkabeS. Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells.Oncotarget.2018

By July 20, 2024No Comments

Leave a Reply